Role of High-Resolution Ultrasound and PET/CT Imaging for Preoperative Characterization of Sentinel Lymph Nodes in Cutaneous Melanoma

Ultrasound in Medicine and Biology

Volumn 39, Issue 1, 2013, Pages 30-36

  Hinz, Torsten ^a   Voth, Harald ^a   Ahmadzadehfar, Hojjat ^a   Hoeller, Tobias ^a   Wenzel, Joerg ^a   Bieber, Thomas ^a   Schmid Wendtner, Monika H ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Interdisciplinary Oncology Center (IOC) Munich   (Germany)

Author keywords

Cutaneous melanoma; High resolution ultrasound; PET CT imaging; Sentinel lymph node

Indexed keywords

BODY FLUIDS; CHARACTERIZATION; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; ULTRASONICS;

CONFIDENCE INTERVAL; CUTANEOUS MELANOMA; HIGH RESOLUTION; NEGATIVE PREDICTIVE VALUE; NODAL METASTASIS; POSITIVE PREDICTIVE VALUES; SENTINEL LYMPH NODES;

DERMATOLOGY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CUTANEOUS MELANOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HIGH RESOLUTION ULTRASOUND; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

EID: 84870328873     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2012.08.024     Document Type: Article

References (40)

1. Balch C.M. Cutaneous melanoma: Prognosis and treatment results worldwide. Semin Surg Oncol 1992, 8:400-414.
2. Blodgett T.M., Meltzer C.C., Townsend D.W. PET/CT: Form and function. Radiology 2007, 242:360-385.
3. Blum A., Schmid-Wendtner M.H., Mauss-Kiefer V., Eberle J.Y., Kuchelmeister C., Dill-Mueller D. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: Results of a prospective multicenter study. Dermatology 2006, 212:47-52.
4. Carlson G.W., Murray D.R., Lyles R.H., Staley C.A., Hestley A., Cohen C. The amount of metastatic melanoma in a sentinel lymph node: Does it have prognostic significance?. Ann Surg Oncol 2003, 10:575-581.
5. Cascinelli N., Belli F., Santinami M., Fait V., Testori A., Ruka W., Cavaliere R., Mozzillo N., Rossi C.R., MacKie R.M., Nieweg O., Pace M., Kirov K. Sentinel lymph node biopsy in cutaneous melanoma: The WHO melanoma Program experience. Ann Surg Oncol 2000, 7:469-474.
6. El-Maraghi R., Kielar A. PET vs. Sentinel lymph node biopsy for staging melanoma: A patient intervention, comparison, outcome analysis. J Am Coll Radiol 2008, 5:924-931.
7. Fink A.M., Holle-Robatsch S., Herzog N., Mirzaei S., Rappersberger K., Lilgenau N., Jurcka W., Steiner A. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res 2004, 14:141-145.
8. Garbe C., Büttner P., Bertz J., Burg G., d'Hoedt B., Drepper H., Guggenmoos-Holzmann I., Lechner W., Lippold A., Orfanos C.E. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995, 75:2484-2491.
9. Gershenwald J.E., Thompson W., Mansfield P.F., Lee J.E., Colome M.I., Tseng C.H., Lee J.J., Balch C.M., Reintgen D.S., Ross M.I. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17:976-983.
10. Gritters L.S., Francis I.R., Zasadny K.R., Wahl R.L. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med 1993, 34:1420-1427.
11. Hinz T., Wilsmann-Theis D., Buchner A., Wenzel J., Wendtner C.M., Bieber T., Reinhard G., Baumert J., Schmid-Wendtner M.H. High-resolution ultrasound combined with Power Doppler sonography can reduce the number of sentinel lymph node biopsies in cutaneous melanoma. Dermatology 2011, 222:180-188.
12. Hocevar M., Bracko M., Pogacnik A., Vidergar-Kralj B., Besic N., Zgajnar J., Music M.M. The role of preoperative ultrasound scan in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res 2004, 14:533-536.
13. Kell M.R., Ridge J.A., Joseph N., Sigurdson E.R. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Oncol 2007, 33:911-913.
14. Klode J., Dissemond J., Grabbe S., Hillen U., Poeppel T., Boeing C. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: A retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II. Dermatol Surg 2010, 36:439-445.
15. Larson S.M., Weiden P.L., Grunbaum Z., Kaplan H.G., Rasey J.S., Graham M.M., Sale G.E., Harp G.D., Williams D.L. Positron imaging feasibility studies II: Characteristic of deoxyglucose uptake in rodent and canine neoplasms: Concise communication. J Nucl Med 1981, 22:875-879.
16. Larson S.M., Schwartz L.H. 18F-FDG PET as a candidate for " qualified biomarker" : Functional assessment of treatment response in oncology. J Nucl Med 2006, 47:901-903.
17. Monzawa S., Adachi S., Suzuki K., Hirokaga K., Takao S., Sakuma T., Hanioka K. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: Comparison with ultrasonography and contrast-enhanced CT. Ann Nucl Med 2009, 23:855-861.
18. Mueller M.L., Forschner A., Wenke A., Luger T.A., Rompel R., Roeder N., Hensen P. G-DRG Version 2009: New developments. J Dtsch Dermatol Ges 2009, 7:318-327.
19. Nieweg O.E. Potential applications of positron emission tomography in surgical oncology. Eur J Surg Oncol 1994, 20:415-424.
20. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Fidler V., Pruim J., Groen H.J. Preoperative staging of non-small-lung cancer with positron emission tomography. N Engl J Med 2000, 343:254-261.
21. Plathow C., Walz M., Lichy M.P., Aschoff P., Pfannenberg C., Bock H., Eschmann S.M., Clausen C.D., Schlemmer H.P. Cost considerations for whole-body MRI and PET/CT as part of oncologic staging. Der Radiologe 2008, 48:384-396.
22. Reinhardt M.J., Joe A.Y., Jaeger U., Huber A., Matthies A., Bucerius J., Roedel R., Strunk H., Bieber T., Biersack H.J., Tueting T. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: Experience with 250 consecutive patients. J Clin Oncol 2006, 24:1178-1187.
23. Rossi C.R., Mocellin S., Scagnet B., Foletto M., Vecchiato A., Pilati P., Tregnaghi A., Zavagno G., Stramare R., Rubatelli L., Montesco C., Borsato S., Rubello D., Lise M. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 2003, 83:80-84.
24. Sanki A., Uren R.F., Moncrieff M., Tran K.L., Scolyer R.A., Lin H.Y., Thompson J.F. Targeted high-resolution ultrasound is not an effective substitute for lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 2009, 27:5614-5619.
25. Schäfer-Hesterberg G., Schoengen A., Sterry W., Voit C. Use of ultrasound to early identify, diagnose and localize metastases in melanoma patients. Exp Rev Anticancer Ther 2007, 7:1707-1716.
26. Schuler A., Reuss J., Delorme S., Hagendorff A., Giesel F. Costs of clinical ultrasound examinations-An economical cost calculation and analysis. Ultraschall Med 2010, 31:379-386.
27. Silverman D.H., Hoh C.K., Seltzer M.A., Schiepers C., Cuan G.S., Gambhir S.S., Zheng L., Czernin J., Phelps M.E. Evaluating tumor biology and oncological disease with positron emission tomography. Semin Radiation Oncol 1998, 8:183-196.
28. Singh B., Ezziddin S., Palmedo H., Reinhardt M., Strunk H., Tueting T., Bieber T., Biersack H.J., Ahmadzadehfar H. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res 2008, 18:346-352.
29. Solbiati L., Rizzatto G., Belotti E. High-resolution sonography of cervical lymph nodes in head and neck cancer: Criteria for differentiation of reactive versus malignant nodes. Radiology 1988, 169:113.
30. Spanknebel K., Coit D.G., Bieligk S.C., Gonen M., Rosai J., Klimstra D.S. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: Recommendations for standardizing pathologic analysis. Am J Surg Pathol 2005, 29:305-317.
31. Starritt E.C., Uren R.F., Scolyer R.A., Quinn M.J., Thompson J.F. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 2005, 12:18-23.
32. Starz H., Balda B.R., Kraemer K.U., Buechels H., Wang H. A micromorphometry- based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001, 91:2110-2121.
33. van Akkoi A.C., Verhoef C., Eggermont A.M. Importance of tumor load in the sentinel node in melanoma: Clinical dilemmas. Nat Rev Clin Oncol 2010, 7:446-454.
34. van Diest P.J. Histopathologic workup of sentinel lymph nodes: How much is enough?. J Clin Pathol 1999, 52:871-873.
35. Vassallo P., Wernecke K., Ross N., Peters P.E. Differentiation of benign from malignant superficial lymphadenpathy: The role of high-resolution US. Radiology 1992, 183:215-220.
36. Voit C., van Akkooi A.C., Schäfer-Hesterberg G., Schoengen A., Kowalczyk K., Roewert J.C., Sterry W., Eggermont A.M. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J Clin Oncol 2010, 28:847-852.
37. Voit C., van Akkooi A.C., Schäfer-Hesterberg G., Schoengen A., Schmitz P.I., Sterry W., Eggermont A.M. Rotterdam criteria for sentinel lymph node (SN) tumor burden and the accuracy of ultrasound (US) - guided fine-needle aspiration cytology (FNAC): Can US-guided FNAC replace SN Staging in patients with melanoma?. J Clin Oncol 2009, 27:4994-5000.
38. Von Schulthess G.K., Steinert H.C., Hany T.F. Integrated PET/CT: Current applications and future directions. Radiology 2006, 238:405-422.
39. Wagner J.D., Schauwecker D., Davidson D., Logan T., Coleman J.J., Hutchins G., Love C., Wenck S., Daggy J. Inefficacy of F-18 Fluorodeoxy-D-Glucose-positron emission tomography scans for initial evaluation in early stage cutaneous melanoma. Cancer 2005, 104:570-579.
40. Wagner J.D., Schauwecker D., Davidson D., Wenck S., Jung S.H., Hutchins G. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol 2001, 77:237-242.